Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
Premature ovarian failure (POF) is a common female reproductive disorder and characterized by menopause, increased gonadotropin levels and estrogen deficiency before the age of 40 years old. The etiologies and pathogenesis of POF are not fully clear. At present, hormone replacement therapy (HRT) is...
Main Authors: | Yanjing Huang, Mengdi Zhu, Zhuo Liu, Runan Hu, Fan Li, Yufan Song, Yuli Geng, Wenwen Ma, Kunkun Song, Mingmin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.997808/full |
Similar Items
-
Corrigendum: Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
by: Yanjing Huang, et al.
Published: (2022-12-01) -
The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure
by: Yantao He, et al.
Published: (2018-10-01) -
Premature Ovarian Insufficiency: Past, Present, and Future
by: Seung Joo Chon, et al.
Published: (2021-05-01) -
Mesenchymal Stem Cells in Premature Ovarian Insufficiency: Mechanisms and Prospects
by: Zhongkang Li, et al.
Published: (2021-08-01) -
Combination of bone marrow mesenchymal stem cells and moxibustion restores cyclophosphamide-induced premature ovarian insufficiency by improving mitochondrial function and regulating mitophagy
by: Ge Lu, et al.
Published: (2024-04-01)